Defunct Company
Total Trials
8
As Lead Sponsor
As Collaborator
0
Total Enrollment
2,144,793
NCT03813862
Observational Pharmaco-Epidemiology Research & Analysis
Phase: N/A
Role: Lead Sponsor
Start: Dec 1, 2013
Completion: Nov 30, 2035
NCT03584048
Charlotte Retention in Care Study
Start: Jul 1, 2018
Completion: Oct 31, 2019
NCT04147832
Epividian / AHF: Positive Pathways - HIV Retention in Care
Start: Oct 5, 2020
Completion: Jul 31, 2021
NCT05104359
COVID-19 Quantitative Antibody Titers & Booster Vaccinations
Start: Dec 11, 2020
Completion: Apr 30, 2022
NCT04863261
Cabenuva Injection Tracking in CHORUS
Start: Oct 1, 2021
Completion: Jul 7, 2022
NCT05495204
External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERA
Start: Aug 5, 2022
Completion: Feb 20, 2023
NCT05710120
Hepatitis C Screening Alerts
Start: Jan 16, 2023
Completion: Oct 17, 2023
NCT05725109
Hepatitis C Diagnosis to Treatment Management